Deprescribing long‐term opioid therapy in patients with chronic pain

Proposed regulatory changes will limit the access to opioids by Australian patients with chronic pain, many of whom are under the care of consultant physicians. This review summarises points of consensus on opioid deprescribing that emerged from the interaction of an expert panel and the audience at a symposium on the topic held in Sydney in 2019. Each of these consensus points speaks to the need for an individualised, patient‐centred approach. In other words, ‘treat the patient, not the pill count’.

[1]  J. Trafton,et al.  Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation , 2020, BMJ.

[2]  S. Rehman,et al.  Flipping the Pain Care Model: A Sociopsychobiological Approach to High-Value Chronic Pain Care. , 2020, Pain medicine.

[3]  C. Meyer-Frießem,et al.  Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage? , 2019, Pain medicine.

[4]  L. Sharpe,et al.  Reducing the use of opioids by patients with chronic pain: an effectiveness study with long-term follow-up. , 2019, Pain.

[5]  W. Compton,et al.  Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics: The HHS Guide for Clinicians. , 2019, JAMA.

[6]  William J. Parish,et al.  Opioid medication discontinuation and risk of adverse opioid-related health care events. , 2019, Journal of substance abuse treatment.

[7]  C. Ashton-James,et al.  Time for change: an experimental investigation of chronic pain patients' emotional and attitudinal responses to simulated opioid-tapering advice. , 2019, Pain.

[8]  M. Bleckwenn,et al.  Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study , 2019, BMJ Open.

[9]  M. Ilgen,et al.  Understanding Links among Opioid Use, Overdose, and Suicide. , 2019, The New England journal of medicine.

[10]  G. Guyatt,et al.  Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis , 2018, JAMA.

[11]  N. Gisev,et al.  Prevalence and incidence of prescription opioid analgesic use in Australia , 2018, British journal of clinical pharmacology.

[12]  M. Inda,et al.  OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients , 2018, Annals of the New York Academy of Sciences.

[13]  R. Helme,et al.  Effects of Electroacupuncture on Opioid Consumption in Patients with Chronic Musculoskeletal Pain: A Multicenter Randomized Controlled Trial , 2018, Pain medicine.

[14]  C. Luedtke,et al.  Longitudinal Treatment Outcomes for an Interdisciplinary Pain Rehabilitation Program: Comparisons of Subjective and Objective Outcomes on the Basis of Opioid Use Status. , 2018, The journal of pain : official journal of the American Pain Society.

[15]  G. Kurita,et al.  Tapering off long‐term opioid therapy in chronic non‐cancer pain patients: A randomized clinical trial , 2018, European journal of pain.

[16]  P. Flood,et al.  Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain , 2018, JAMA internal medicine.

[17]  Tessa Rife,et al.  An Electronic Intervention to Improve Safety for Pain Patients Co-Prescribed Chronic Opioids and Benzodiazepines , 2018, Substance abuse.

[18]  T. Ortega,et al.  Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis , 2018, The mental health clinician.

[19]  K. Kroenke,et al.  Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial , 2018, JAMA.

[20]  PharmD Bcps Lauren Hundley,et al.  Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System. , 2018 .

[21]  Stephen G. Henry,et al.  Communication about chronic pain and opioids in primary care: impact on patient and physician visit experience , 2018, Pain.

[22]  K. Lasser,et al.  Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial , 2017, JAMA internal medicine.

[23]  Joseph W. Frank,et al.  Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy , 2017, Annals of Internal Medicine.

[24]  S. Dobscha,et al.  Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. , 2017, General hospital psychiatry.

[25]  J. Scheman,et al.  Sustained improvements in pain, mood, function and opioid use post interdisciplinary pain rehabilitation in patients weaned from high and low dose chronic opioid therapy , 2017, Pain.

[26]  R. Kerns,et al.  Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans , 2017, Pain.

[27]  Joseph W. Frank,et al.  Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. , 2016, Pain medicine.

[28]  I. Danovitch,et al.  A preoperative interdisciplinary biopsychosocial opioid reduction program in patients on chronic opioid analgesia prior to spine surgery: A preliminary report and case series , 2016, Scandinavian journal of pain.

[29]  J. Cunningham,et al.  OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program , 2016 .

[30]  K. Eagar,et al.  Establishment of the Australasian Electronic Persistent Pain Outcomes Collaboration , 2016, Pain medicine.

[31]  W. Rief,et al.  Do we need a third mechanistic descriptor for chronic pain states? , 2016, Pain.

[32]  S. King.  CDC Guideline for Prescribing Opioids for Chronic Pain , 2016 .

[33]  A. Aggarwal,et al.  Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain , 2016, Journal of pain & palliative care pharmacotherapy.

[34]  Roger Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[35]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[36]  Daniel M. Hartung,et al.  A Chronic Opioid Therapy Dose Reduction Policy in Primary Care , 2016, Substance abuse.

[37]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[38]  Rachelle Buchbinder,et al.  The global burden of low back pain: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[39]  T. Gomes,et al.  Opioid dose and drug-related mortality in patients with nonmalignant pain. , 2011, Archives of internal medicine.

[40]  E. Bruera,et al.  Critical issues on opioids in chronic non-cancer pain: An epidemiological study , 2006, Pain.

[41]  F. Blyth,et al.  Are self-management strategies effective in chronic pain treatment? , 2016, Pain management.